-
555 Beiträge
-
0 Fotos
-
0 Videos
-
Female
-
Follower 0 Menschen
Neueste Updates
-
Rheumatoid arthritis vs. psoriasis: two diseases, one drug classRheumatoid arthritis (RA) is an autoimmune disease that attacks joints. Psoriasis attacks the skin. But both involve TNF-alpha. The US tumor necrosis factor alpha inhibitors market research study shows that RA is the largest indication, but psoriasis is the fastest‑growing. Why? Because new biologics (IL‑17, IL‑23 inhibitors) are competing for psoriasis, but TNF inhibitors remain...0 Kommentare 0 Geteilt 312 Ansichten 0 BewertungenBitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Subcutaneous vs. intravenous TNF inhibitors: which one is right for you?Subcutaneous (SC) injections are given at home — they're convenient and less expensive. Intravenous (IV) infusions are given in a clinic — they're more invasive but allow for higher doses and faster action. The TNF alpha inhibitors market research study shows that SC holds the largest share, but IV is the fastest‑growing, especially for acute flares or for patients who...0 Kommentare 0 Geteilt 315 Ansichten 0 Bewertungen
-
Hospitals vs. specialty centers: where should you get ablation?Hospitals are the largest end‑user segment — they have the interventional radiology suites, the anaesthesia support, and the backup for complications. But specialty centers are the fastest‑growing. The US tumor ablation market research study shows that specialty centers are growing at over 10% CAGR, because they focus exclusively on minimally invasive procedures and offer a...0 Kommentare 0 Geteilt 322 Ansichten 0 Bewertungen
-
Hospitals vs. specialty centers: where should you get ablation?Hospitals are the largest end‑user segment — they have the interventional radiology suites, the backup for complications, and the multidisciplinary teams. But specialty centers (cancer centres) are the fastest‑growing. The tumor ablation market research study shows that specialty centers are growing at over 12% CAGR, because they focus on cancer and offer integrated care...0 Kommentare 0 Geteilt 328 Ansichten 0 Bewertungen
-
Hospitals vs. diagnostic labs: where are tularemia cases detected?Hospitals are the largest end‑user segment — they see the sickest patients and order the tests. But diagnostic laboratories are the fastest‑growing. The US tularemia market research study shows that labs are growing at over 5% CAGR, driven by reference labs (Quest, LabCorp) offering tularemia PCR and serology. What's the advantage of a reference lab? They have validated tests...0 Kommentare 0 Geteilt 349 Ansichten 0 Bewertungen
-
Hospitals vs. research labs: who's driving tularemia preparedness?Hospitals are the largest end‑user segment — they diagnose and treat tularemia cases. But research institutions are the fastest‑growing. The tularemia market research study shows that research labs are growing at over 5% CAGR, driven by government funding for biodefense. Why? Because tularemia is a potential bioweapon, and we need better vaccines and rapid diagnostics. What's...0 Kommentare 0 Geteilt 408 Ansichten 0 Bewertungen
-
Subscription vs. pay‑per‑visit: which online doctor model wins?Subscription models (e.g., $50/month for unlimited visits) are great for chronic conditions — you see the same doctor regularly, building continuity. Pay‑per‑visit ($40‑$80 per consult) is good for acute issues — a rash, a cold, a prescription refill. The online doctor consultation market research study shows that subscription holds the largest share, but pay‑per‑visit...0 Kommentare 0 Geteilt 305 Ansichten 0 Bewertungen
-
The rise of nasal vaccines: COVID changed everythingInjected vaccines work, but nasal vaccines could be even better — they induce mucosal immunity in the nose and throat, where respiratory viruses enter. The nasal spray market research study shows that the vaccination application is small but the fastest‑growing, with a CAGR above 10%. Why the excitement? Because nasal vaccines are needle‑free, painless, and easier to...0 Kommentare 0 Geteilt 284 Ansichten 0 Bewertungen
-
Nanoparticles vs. nanocomposites: which material is winning the race?Nanoparticles (gold, silver, iron oxide) are the workhorses — they're used in imaging, drug delivery, and biosensing. Nanocomposites (combining nanoparticles with polymers) are the up‑and‑comers — they offer better mechanical properties and biocompatibility. The nano healthcare technology market research study shows that nanoparticles hold the largest share, but...0 Kommentare 0 Geteilt 308 Ansichten 0 Bewertungen
-
Bariatric surgery: drastic, but it cures metabolic syndrome in 80% of patientsLet's be real: surgery seems extreme. But for people with severe obesity (BMI >40) or BMI >35 with complications, bariatric surgery (gastric bypass, sleeve) is the most effective treatment. The metabolic syndrome market forecast shows that surgery is the fastest‑growing treatment segment, with a CAGR above 9%. Why? Because it doesn't just reduce weight — it changes gut...0 Kommentare 0 Geteilt 291 Ansichten 0 Bewertungen
-
Online vs. pharmacies: where should you buy your menstrual cup?Online stores are the largest channel — you can browse hundreds of brands, read reviews, and have the cup delivered discreetly. Pharmacies are the fastest‑growing channel. The menstrual cup market research study shows that pharmacies are growing at over 18% CAGR, driven by the need for immediate availability and the trust associated with physical stores. What's the advantage...0 Kommentare 0 Geteilt 308 Ansichten 0 Bewertungen
-
Hospitals vs. telemedicine: where should you get a second opinion?Hospitals are the largest end‑user segment — they have the specialists, the tumour boards, and the multidisciplinary teams. But telemedicine platforms are the fastest‑growing. The medical second opinion market research study shows that telemedicine is growing at over 18% CAGR, because it's convenient and often cheaper. What's the advantage of a hospital? You can get a second...0 Kommentare 0 Geteilt 384 Ansichten 0 Bewertungen
Mehr Storys